Korro Bio (KRRO) Total Debt (2018 - 2023)
Korro Bio's (KRRO) quarterly Total Debt came in at $11.7 million in Q1 2023, down 22.22% on a YoY basis from $15.0 million in Q1 2022, and down 17.65% quarter-over-quarter from $14.2 million in Q4 2022.
Analysis
Korro Bio (KRRO) Total Debt (2018 - 2023) Analysis & Trends
Korro Bio (KRRO) has reported Total Debt for 6 consecutive years, with $11.7 million the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, Total Debt fell 22.22% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2023 stood at $11.7 million (down 22.22% YoY), and the FY2022 full-year result was $14.2 million, down 5.55% from the prior year.
- Total Debt slipped to $11.7 million in Q1 2023 per KRRO's latest filing, from $14.2 million in the prior quarter.
- Across five years, Total Debt topped out at $15.0 million in Q4 2020 and bottomed at $180000.0 in Q4 2019.
- Historically, Total Debt has averaged $12.2 million across 5 years, with a median of $15.0 million in 2020.
- The sharpest annual moves came in 2019 and 2020: Total Debt sank 48.42% in 2019, then surged 8233.33% in 2020.
- Over 5 years, Total Debt stood at $180000.0 in 2019, then soared by 8233.33% to $15.0 million in 2020, then changed by 0.0% to $15.0 million in 2021, then slipped by 5.55% to $14.2 million in 2022, then fell by 17.65% to $11.7 million in 2023.
- According to Business Quant data, Total Debt over the past three periods registered $11.7 million, $14.2 million, and $15.0 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 62.75 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 28.66 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 8.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Korro Bio | 231.15 Mn | 116.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 11.67 Mn |
| Dec 31, 2022 | 14.17 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 15.00 Mn |
| Mar 31, 2022 | 15.00 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 15.00 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Mar 31, 2021 | 15.00 Mn |
| Dec 31, 2020 | 15.00 Mn |
| Dec 31, 2019 | 180,000.00 |
| Sep 30, 2019 | 222,000.00 |
| Dec 31, 2018 | 349,000.00 |